For research use only. Not for therapeutic Use.
Omidenepag (Cat.No:I008028) is a prostaglandin analog used in ophthalmology for the treatment of glaucoma and ocular hypertension. It acts by reducing intraocular pressure through selective activation of the prostaglandin FP receptor. Omidenepag offers an effective alternative for lowering eye pressure and has shown good tolerability in clinical studies.
| Catalog Number | I008028 |
| CAS Number | 1187451-41-7 |
| Synonyms | Omidenepag; CAS#1187451-41-7.;(6-((N-(4-(1H-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycine |
| Molecular Formula | C23H22N6O4S |
| Purity | ≥95% |
| Target | Prostaglandin Receptor |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| IUPAC Name | 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetic acid |
| InChI | InChI=1S/C23H22N6O4S/c30-23(31)15-25-22-6-1-4-19(27-22)17-28(34(32,33)21-5-2-11-24-14-21)16-18-7-9-20(10-8-18)29-13-3-12-26-29/h1-14H,15-17H2,(H,25,27)(H,30,31) |
| InChIKey | YHGSTSNEOJUIRN-UHFFFAOYSA-N |
| SMILES | C1=CC(=NC(=C1)NCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4 |
